FIELD: medicine.
SUBSTANCE: methods of the invention involve introduction of (R)-3-[1-(2,6-dichlor-3-fluorophenyl)ethoxy]-5-(1-piperidine-4-yl-1H-pyrazole-4-yl)pyridine-2-ylamine (Compound 1) for treating the abnormal cell expansion and inhibition of activity of kinase s-Met/HGFR in a cell.
EFFECT: application of the inventions enables to inhibit growth of tumor ensured by inhibition of genetically changed kinases of receptor of hepatocyte and anaplastic lymphoma (ALK) growth factor with compound 1.
11 cl, 5 tbl, 11 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CHIRAL DIARYL MACROCYCLES AND USE THEREOF | 2016 |
|
RU2728579C2 |
| ANTIBODIES BOUND TO EXTRACELLULAR DOMAIN OF TYROSINE KINASE RECEPTOR (ALK) | 2007 |
|
RU2460540C2 |
| PHOSPHORUS CONTAINING COMPOUNDS AS PROTEIN KINASE INHIBITORS | 2012 |
|
RU2598849C2 |
| COMBINED C-MET AND EGFR ANTAGONISTS THERAPY | 2009 |
|
RU2601892C2 |
| HUMANISED ANTI c-met ANTAGONISTS | 2005 |
|
RU2398777C2 |
| PROTEIN, METHOD OF PROTEIN PREPARING (VARIANTS), PHARMACEUTICAL COMPOSITION | 1992 |
|
RU2124024C1 |
| SUBSTITUTED QUINOLINE COMPOUNDS AND METHODS OF THEIR APPLICATION | 2012 |
|
RU2568258C2 |
| NEW CHEMICAL COMPOUNDS (VERSIONS) AND USING THEM FOR TREATING ONCOLOGICAL DISEASES | 2013 |
|
RU2550346C2 |
| C-MET/HGFR INHIBITOR POLYMORPHS | 2006 |
|
RU2387650C2 |
| SUBSTITUTED PIRIDAZINE-CARBOXAMIDE COMPOUNDS AS KINASE-INHIBITING COMPOUNDS | 2009 |
|
RU2526618C2 |
